Found: 16
Select item for more details and to access through your institution.
CBX4 promotes antitumor immunity by suppressing Pdcd1 expression in T cells.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2694, doi. 10.1002/1878-0261.13516
- By:
- Publication type:
- Article
KLF12 transcriptionally regulates PD‐L1 expression in non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2659, doi. 10.1002/1878-0261.13512
- By:
- Publication type:
- Article
Pharmacological NF‐κB inhibition decreases cisplatin chemoresistance in muscle‐invasive bladder cancer and reduces cisplatin‐induced toxicities.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2709, doi. 10.1002/1878-0261.13504
- By:
- Publication type:
- Article
Dinaciclib synergizes with BH3 mimetics targeting BCL‐2 and BCL‐X<sub>L</sub> in multiple myeloma cell lines partially dependent on MCL‐1 and in plasma cells from patients.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2507, doi. 10.1002/1878-0261.13522
- By:
- Publication type:
- Article
Downregulation of RCN1 promotes pyroptosis in acute myeloid leukemia cells.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2584, doi. 10.1002/1878-0261.13521
- By:
- Publication type:
- Article
A guide to epigenetics in leukaemia stem cells.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2493, doi. 10.1002/1878-0261.13544
- By:
- Publication type:
- Article
TAZ facilitates breast tumor growth by promoting an immune‐suppressive tumor microenvironment.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2675, doi. 10.1002/1878-0261.13525
- By:
- Publication type:
- Article
Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2618, doi. 10.1002/1878-0261.13500
- By:
- Publication type:
- Article
ANGPTL2‐mediated epigenetic repression of MHC‐I in tumor cells accelerates tumor immune evasion.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2637, doi. 10.1002/1878-0261.13490
- By:
- Publication type:
- Article
Synergistic inhibition of NUDT21 by secretory S100A11 and exosomal miR‐487a‐5p promotes melanoma oligo‐ to poly‐metastatic progression.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2743, doi. 10.1002/1878-0261.13480
- By:
- Publication type:
- Article
Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2565, doi. 10.1002/1878-0261.13486
- By:
- Publication type:
- Article
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2728, doi. 10.1002/1878-0261.13485
- By:
- Publication type:
- Article
Expression of cancer–testis antigens in the immune microenvironment of non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2603, doi. 10.1002/1878-0261.13474
- By:
- Publication type:
- Article
Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2546, doi. 10.1002/1878-0261.13386
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2491, doi. 10.1002/1878-0261.13242
- Publication type:
- Article
The synthetic oleanane triterpenoid CDDO‐2P‐Im binds GRP78/BiP to induce unfolded protein response‐mediated apoptosis in myeloma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 12, p. 2526, doi. 10.1002/1878-0261.13447
- By:
- Publication type:
- Article